Clinical Trials · NCT03466021
Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Claus Bogh Juhl
- Enrollment
- 40
- Start date
- Jan 2018
- Locations
- 2 sites, Denmark
- Primary endpoint
- Transition Dyspnea Index (TDI)